Ispecimen Stock Performance
| ISPC Stock | USD 3.48 0.49 12.34% |
On a scale of 0 to 100, ISpecimen holds a performance score of 1. The company retains a Market Volatility (i.e., Beta) of -2.48, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning ISpecimen are expected to decrease by larger amounts. On the other hand, during market turmoil, ISpecimen is expected to outperform it. Please check ISpecimen's potential upside, as well as the relationship between the daily balance of power and price action indicator , to make a quick decision on whether ISpecimen's current trending patterns will revert.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in iSpecimen are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, ISpecimen exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (12.56) | Five Day Return (10.31) | Year To Date Return (66.86) | Ten Year Return (97.57) | All Time Return (97.57) |
Last Split Factor 1:20 | Last Split Date 2024-09-16 |
1 | Insider Trading | 09/25/2024 |
2 | iSpecimen Faces Ex-Executives Financial Claims, Regains Nasdaq Compliance - TipRanks | 10/02/2024 |
3 | Disposition of 1668 shares by Basile Joseph J. of ISpecimen at 1.5 subject to Rule 16b-3 | 10/07/2024 |
4 | iSpecimen files to sell 1.2M shares of common stock | 10/18/2024 |
5 | Acquisition by Scholl George H. of 13525 shares of ISpecimen at 8.0 subject to Rule 16b-3 | 10/21/2024 |
6 | iSpecimen Inc. Announces Closing of 5 Million Public Offering of Common Stock and Pre-Funded Warrants | 10/31/2024 |
7 | iSpecimen Releases Cancer Biospecimen Offering Orders Anticipated of Over 9,500,000 Annually | 11/07/2024 |
8 | iSpecimen stock hits 52-week low at 3.4 amid market challenges - Investing.com | 12/11/2024 |
| Begin Period Cash Flow | 15.3 M |
ISpecimen |
ISpecimen Relative Risk vs. Return Landscape
If you would invest 386.00 in iSpecimen on September 13, 2024 and sell it today you would lose (38.00) from holding iSpecimen or give up 9.84% of portfolio value over 90 days. iSpecimen is currently generating 0.2094% in daily expected returns and assumes 8.9446% risk (volatility on return distribution) over the 90 days horizon. In different words, 79% of stocks are less volatile than ISpecimen, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ISpecimen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ISpecimen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as iSpecimen, and traders can use it to determine the average amount a ISpecimen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0234
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ISPC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.94 actual daily | 79 79% of assets are less volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average ISpecimen is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ISpecimen by adding it to a well-diversified portfolio.
ISpecimen Fundamentals Growth
ISpecimen Stock prices reflect investors' perceptions of the future prospects and financial health of ISpecimen, and ISpecimen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ISpecimen Stock performance.
| Return On Equity | -1.09 | ||||
| Return On Asset | -0.44 | ||||
| Profit Margin | (0.92) % | ||||
| Operating Margin | (0.64) % | ||||
| Current Valuation | 3.15 M | ||||
| Shares Outstanding | 962.64 K | ||||
| Price To Earning | 0.78 X | ||||
| Price To Book | 0.81 X | ||||
| Price To Sales | 0.37 X | ||||
| Revenue | 9.93 M | ||||
| Gross Profit | 5.65 M | ||||
| EBITDA | (9.1 M) | ||||
| Net Income | (11.1 M) | ||||
| Cash And Equivalents | 23.69 M | ||||
| Cash Per Share | 2.67 X | ||||
| Total Debt | 196.24 K | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 13.37 X | ||||
| Book Value Per Share | 5.68 X | ||||
| Cash Flow From Operations | (5.81 M) | ||||
| Earnings Per Share | (18.12) X | ||||
| Market Capitalization | 3.82 M | ||||
| Total Asset | 15.82 M | ||||
| Retained Earnings | (59.36 M) | ||||
| Working Capital | 2.19 M | ||||
About ISpecimen Performance
By analyzing ISpecimen's fundamental ratios, stakeholders can gain valuable insights into ISpecimen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ISpecimen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ISpecimen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.29) | (1.36) | |
| Return On Capital Employed | (1.14) | (1.09) | |
| Return On Assets | (0.70) | (0.74) | |
| Return On Equity | (1.14) | (1.08) |
Things to note about iSpecimen performance evaluation
Checking the ongoing alerts about ISpecimen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for iSpecimen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| iSpecimen had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 9.93 M. Net Loss for the year was (11.1 M) with profit before overhead, payroll, taxes, and interest of 5.65 M. | |
| iSpecimen currently holds about 23.69 M in cash with (5.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.67. | |
| Roughly 15.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: iSpecimen stock hits 52-week low at 3.4 amid market challenges - Investing.com |
- Analyzing ISpecimen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ISpecimen's stock is overvalued or undervalued compared to its peers.
- Examining ISpecimen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ISpecimen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ISpecimen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ISpecimen's stock. These opinions can provide insight into ISpecimen's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ISpecimen Stock analysis
When running ISpecimen's price analysis, check to measure ISpecimen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ISpecimen is operating at the current time. Most of ISpecimen's value examination focuses on studying past and present price action to predict the probability of ISpecimen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ISpecimen's price. Additionally, you may evaluate how the addition of ISpecimen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |